chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling in neck; Swelling in underarm glands; Swelling on the outer part of of left breast; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 06May2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 21:30, the patient experienced swelling in neck and underarm glands and swelling on the outer part of left breast. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events swelling in neck and underarm glands and swelling on the outer part of left breast was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
approx 2hr p/vax pt had shaking all over the body w/peripheral cyanosis & mottling of skin;given DPH;
This infant had Bell's Palsy on the right side of his face. He eats okay. Mother says the MD thought it was a reaction to HBV vaccine.
Patient reported having heart palpitations an hour after receiving the vaccine. She took her heart medication and was fine.
This spontaneous report as received from a licensed vocational nurse refers to an unspecified number of patients of unknown age and gender. No information on patients medical history or concurrent conditions was provided. On unknown dates, the patients were vaccinated with doses of improperly (Merck) VARIVAX (dose numbers, frequency, route of administration, lot# and expiration date were not reported). No information on patients concomitant medication was provided. No adverse effects reported. Additional information has been requested.
About 10 minutes after receiving vaccine, patient reported feeling hot and not well.  Patient had not eatten breakfast prior to appointment.  Patient's oxygen sat was 100% but heart rate initially 42 (normal range 55-65) and blood pressure 90/60 (normal for him). Patient was diaphoretic and  was given crackers and juice.  Patient's symptoms continue to progress with heart rate down as low as 34. Due to progression of symptoms, patient was taken to the ER.
Sneezing -12 hours, runny nose- 24 hours, mild cough 24 hours, fatigue for 36 hours, mild headache12 hours,  muscle aches.  Used OTC multi symptom  cold medicine and Allegra.
PATIENT WAS ASKED TO STAY 30 MINUTES INSTEAD OF 15 MINUTES DUE TO REPORTS OF PAST ISSUES WITH VASOVAGAL EPISODES POST BLOOD WORK. DURING MINUTE 23, HE LOWERED HIMSELF FROM THE CHAIR TO THE FLOOR AS HE FELT DIAPHORETIC, WAS PALE, AND ANXIOUS. HE DID NOT LOSE CONSCIOUSNESS AND QUESTIONS WHETHER IT WAS A PANIC ATTACK DUE TO OTHERS WAITING NEAR HIM IN THE OBSERVATION ROOM.  PATIENT STAYED AFTER RAPID RESPONSE WAS CALLED. Doctor FROM THE HOSPITAL EVALUATED THE PATIENT. HE RECOMMENDED THE PATIENT COME TO THE ED FOR BLOOD WORK AND AN EKG, BUT PATIENT REFUSED. HE STAYED IN THE VACCINE ROOM FOR 1 HOUR LAYING, HAVING SNACKS AND SLOWLY WALKED OUT TO HIS RIDE WITH NO ISSUES. HIS BP/HR/O2 WAS CHECKED AND ALWAYS NORMAL. ICE PACK GIVEN TO TAKE HOME ALONG WITH JUICE, WATER, AND PEANUT BUTTER CRACKERS.
Sensitivity/soreness in gums/teeth, numbness in fingers, arm, arm, and lips.
04Jun90 pt recvd booster vax; Pt started wheezing w/ chest contractions, cyanosis & severe itching.  Seen in ER where it was noted pt had gen erythema.  Admitted to hosp & tx w/ EPI & Ventolin.
Arm pain started around 4:30pm - hurt to pick up water bottle. Throat pain started 5:30pm - feels like strep throat
chills; pulse was up; blood pressure was up; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (pulse was up), BLOOD PRESSURE INCREASED (blood pressure was up) and CHILLS (chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history information provided by the reporter.  Concomitant products included LISINOPRIL and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced HEART RATE INCREASED (pulse was up) and BLOOD PRESSURE INCREASED (blood pressure was up). On an unknown date, the patient experienced CHILLS (chills). At the time of the report, HEART RATE INCREASED (pulse was up) and BLOOD PRESSURE INCREASED (blood pressure was up) had resolved and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 12-Mar-2021: New info about dose, new AEs added.
Pt became dizzy at 232 after vaccination at 2:27, she was assisted to floor, mother was present, assessed with blood pressure check noted to be 100/62, HR 88 Pulse ox 99%, pt stated felt dizzy. Continued to observe assisted to sitting position , no c/o dizziness. 2:39 pt remained alert and oriented. Continued to monitor additional 15 minutes 315 BP 113/70 , no further treatment per mother, left with mother, encouraged follow up with MD if symptoms return.
Local redness - swelling (ecchymesis w/erythema) (R) arm. Was seen at appointment but no tx was needed. The reaction was due to PNEUMOVAX & over-65 Flu vacc in same arm.
swollen injection site; painful injection site; red streaks from injection site running down under his arm; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 52-year-old male patient who received Herpes zoster (Shingrix) (batch number 4X733, expiry date 8th March 2021) for prophylaxis.   On 15th April 2019, the patient received the 2nd dose of Shingrix (intramuscular). In April 2019, less than a week after receiving Shingrix, the patient experienced injection site swelling, injection site pain and injection site erythema. On an unknown date, the outcome of the injection site swelling, injection site pain and injection site erythema were not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling, injection site pain and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on left arm. The patient experienced swollen and painful injection site and red streaks from injection site running down under his arm.
Patient, 13 years old received on 2/3/22 Pfizer (12 +years)  1st dose , but then on 3/1/22 he came to the pharmacy and by accident the immunizer technician, administered by accident a pediatric Pfizer vaccine. The patient sister (guardian and person who brought the patient to the pharmacy older than 21 yo) got notified by pharmacist about the error. Pharmacist explained after researching the CDC did not recommend to repeat dose in this situation and to wait 5 months for the booster if desired. Patient sister agreed on the recommendation.
TESTED POSITIVE FOR COVID; This spontaneous case was reported by a consumer and describes the occurrence of   in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, LOSARTAN and ATORVASTATIN for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Tylenol, Vitamin C immune support, Zinc, Vitamin D3, Mucinex
On July 1, 2019 a Nurse Practitioner student gave the wrong medication. The patient was to receive Tubersol 0.1m intradermal to the left arm, volar surface. Instead she gave Tetanus and Diptheria Toxoids Adsorbed, unknown if 0.5 ml or 0.1 ml given and unknown if given subcutaneous or intradermal. Pt developed localized allergic reaction, sought treatment the same day at urgent care and was Rx'd prednisone 50 mg po qd x 5 days. she reported back to clinic on July 3rd, was to continue Prednisone which she had not started until that day. returned on July 5th and noted to have a cellulits starting. Started on Keflex 500 mg po tid and she is following w her PCP.
request for medical records for client for another program on 3/12/04. Records received 3/30/04. Visit to Dr's office 1/31/04 states abnormal head movements and abnormal visual tracking. Questions adverse reaction to immunizations.
Soreness for one day. Joint and muscle aches and pains throughout body, shivers and fever Day following injection. Redness at injection site for one week.
tachycardia began within the firs minute of injection and lasted up to 3 minutes.  with feelings of light headed.
min local reaction @ inject; sl edema & brushing; approx 9PM 11MAY93 pt began crying persistently-piercing-irritable cry; ext & face swollen w/large welps;
Pt reports 7 days of itching, redness and swelling of upper arm after receiving PREVNAR 13 on 1/10/19.
About 1.5 weeks after the second shot which was given on May 19, 2021, I started to have daily heart palpitations and I lost hearing in my right ear.   The heart palpitations were frequent during exercise (about every 5 minutes).  When not exercising, I was having one about every 6 hours.  The hearing loss was not 100%...I could hear about 15%.  There was no pain or ringing.  The heart palpitations continue, although today (July 18, 2021) is the third day in a row with no palpitations so I am hopeful it has now resolved - I will mark the recovery as unknown for now.  The ear clog resolved itself around July 3rd after treatment with flonase.
Top of the left hand shows broken capillaries; Some sport of blood coming out of those broken capillaries; Huge blood veins sticking out of patient's wrist like a snake; Bumps over both the knuckles.; This spontaneous case was reported by a consumer and describes the occurrence of PETECHIAE (Top of the left hand shows broken capillaries), CAPILLARY FRAGILITY (Some sport of blood coming out of those broken capillaries), VASODILATATION (Huge blood veins sticking out of patient's wrist like a snake) and KNUCKLE PADS (Bumps over both the knuckles.) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Back pain. Concomitant products included DICLOFENAC SODIUM (PROFENAC) for Back pain, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (SINUS MEDICATION) for an unknown indication.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced PETECHIAE (Top of the left hand shows broken capillaries), CAPILLARY FRAGILITY (Some sport of blood coming out of those broken capillaries), VASODILATATION (Huge blood veins sticking out of patient's wrist like a snake) and KNUCKLE PADS (Bumps over both the knuckles.). At the time of the report, PETECHIAE (Top of the left hand shows broken capillaries), CAPILLARY FRAGILITY (Some sport of blood coming out of those broken capillaries), VASODILATATION (Huge blood veins sticking out of patient's wrist like a snake) and KNUCKLE PADS (Bumps over both the knuckles.) had not resolved.            Other Concomitant product information includes Supplements. Treatment information was not provided.   This case was linked to MOD-2021-073125 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Outcome of the events were changed from unknown to not recovered.Symptoms are still ongoing.
Patient passed out during the observation time. Patient was moved to the floor and feet were elevated. Patient regained consciousness and was monitored by the pharmacist. 911 had been called by the time patient regained consciousness. EMTs arrived and took over scene. Patient was able to walk with EMTs on his own. No medications were given by the pharmacy/pharmacist.
local rxn @ inj site lt deltoid red/hot/swollen;mom tried witch hazel & top DPH;instructed to use hydrocortisone 1% PRN discomfort;
After I had the 2nd dosage of the Moderna shot and it felt like I was going to have a heart attack (like someone threw a blanket over me because I became clammy, sweaty, and weak. I went to see my Doctor and she did an EKG in the office and decided that I need to go to see a Cardiology as a precaution. The Cardiologist will be performing an Echo Cardiogram an a stress test on my heart.
Pt with 3-4cm pale pink area on (L) deltoid. Symptoms started Monday night and pt improved compared to picture taken Thursday.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXTRA DOSE ADMINISTERED (I just had a second booster shot of Moderna vaccine 60 days after my first booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXTRA DOSE ADMINISTERED (I just had a second booster shot of Moderna vaccine 60 days after my first booster.). On 25-Jan-2022, EXTRA DOSE ADMINISTERED (I just had a second booster shot of Moderna vaccine 60 days after my first booster) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were provided. No treatment information were given. Reporter did not allow further contact.
chest pain-- lingering; did have muscle aches on day 1 but then lingering chest pain isolated on day 2 post vaccine No shortness of breath, N/V, radiation of pain, ibuprofen helpful
Herpes zoster with ophthalmic complications; Uncontrolled glaucoma in both eyes; Optic nerve damage; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On or about 20-SEP-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dosage and route of administration were not provided) for routine health maintenance and for the prevention of shingles (herpes zoster). On an unspecified date, shortly after receiving zoster vaccine live (ZOSTAVAX) the patient suffered severe, painful and debilitating shingles across her forehead and eye area. These blisters and rashes caused permanent scarring above the patient's eyebrows. The patient developed increased preassure resulting in extrema pain, water and redness in both eyeballs. The patient suffered decreased vision. She was formally diagnosed with herpes zoster with ophthalmic complications, uncontrolled glaucoma in both eyes and optic nerve damage. The patient underwent extensive treatment as a result of her singles diagnosis and eye complications, including surgical trabeculotomies on both eyes in order to lower the intraocular pressure associated with glaucoma. All of these injuries were caused by zoster vaccine live (ZOSTAVAX). It was also specified that the patient suffered serious, progressive, permanent, and incurable disfiguring injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life and physical impairment.  Upon internal Review, ophthalmic herpes zoster, optic nerve injury and glaucoma were considered medically significant. The events were considered to be disabling due to the severe, permanent and incurable injuries.
Patient states that she is anxious and is experiencing tingling in her legs. Her legs checked and appear normal. Her vital was checked  BP 122/84 O2 sat 98 HR 80 She appeared normal and she was released to go home.
Pt had soreness and swelling at the site by that evening. She also noticed 3 horizontal lines that went down her arm underneath the injection site but they were not present when the patient was seen in the office. The site was still tender to touch & had some swelling.
Pt received flu shot at work on 10/13/2005, the evening of the flu shot she began to feel tired and started with fevers. Fevers continued through 11/08/2005 ranging 100.5 - 101.3. no UA, no culture no mono no CBC. Please contact her employer where she received the flu shot for this information.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included shingles. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced shingles, condition aggravated, feeling unwell, drug use for unapproved indication and off label use. On an unknown date, the outcome of the shingles, condition aggravated and feeling unwell were not recovered/not resolved and the outcome of the drug use for unapproved indication and off label use were unknown. It was unknown if the reporter considered the shingles, condition aggravated and feeling unwell to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient was vaccinated with SHINGRIX by his health care provider in the middle of a case of Shingles, while the infection was still active. The health care provider was wondering why it was recommended to patient who had an outbreak of shingles, which led to drug use for unapproved indication and off label use. The patient has ongoing side effects after becoming very ill in the two days after the immunization.
Rash on back, close to left neck, and a little to the right; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on back, close to left neck, and a little to the right) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced RASH (Rash on back, close to left neck, and a little to the right). At the time of the report, RASH (Rash on back, close to left neck, and a little to the right) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment information  was provided.   This case was linked to MOD-2021-114508 (Patient Link).
sore arm; stung at injection site/ she experienced tenderness at the site; felt lousy; This case was reported by a consumer via call center representative and described the occurrence of feeling bad in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd October 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 4 months after receiving Shingrix, the patient experienced feeling bad, pain in arm and injection site pain. On an unknown date, the outcome of the feeling bad, pain in arm and injection site pain were recovered/resolved.   It was unknown if the reporter considered the feeling bad, pain in arm and injection site pain to be related to Shingrix.  Additional information received were as follows: This case was reported by patient herself. The patient received a dose of Shingrix on the left arm. The patient felt lousy, but the symptoms resolved after 3 to 4 days. The patient arm was so sore and she could not lay on her side and it stung at the injection site and she experienced tenderness at the site. For tolerance with 2nd dose refer linked case US2020AMR019492.
Patient received fluzone high dose vaccine on October 1, 2019. Patient called pharmacy where she received flu vaccine on April 11, 2020 to ask when she had received the vaccine and was stating that her arm was still very sore at the injection site. Patient was asked what she had tried to help with soreness and asked if she had seen a doctor and she had not at this time. We showed our concern and recommended she reach out to her PCP to see about getting her arm checked out and to let us know if she had any further questions.
G62.9 PERIPHERAL NEUROPATHY 2/20/2023 HYPOXIA I21.4 ACUTE NON ST ELEVATION MI 3/6/2023 HYPOXIA I24.8 DEMAND ISCHEMIA 3/6/2023 HYPOXIA
Developed hives all over the body, difficulty swallowing, itchiness, tingling, SOB,  mild chest tightness 9 min following the first dose of the vaccine on 01/11/21and was treated with IV Benadryl, Pepcid and Hydrocortisone.  Since the vaccine on 01/11 patient c/o prolonged fatigue and intermittent episodes of palpitations, chest tightness resolving without intervention. (2-3 episodes )  01/20 patient reported symptoms of chest tightness, full body shaking requiring medical attention and d/c from care.
Patient received Tdap vaccine on 7-25-12. Woke up next AM 7-26-12 with chills and temp of 102.6. Pt phoned PCP - sent her to ER. Pt was admitted to ER on 7-26-12. Dx. with slight bladder infection and pneumonia, now currently recovering. Still in hospital as of 7/30/12.
Developed Covid Arm immediately within 1 hour of  second injection.  it persists 3 days later. After 16hrs developed chills, fever of 101, nausea and fatigue. Very ill for 24hrs then slowly recovered to normal over 2 days.
Fever one day after vaccinations. Vomiting and weight loss beginning one week after ROTATEQ administered on 9/13/07. Continued chronic GI problems. Failure to thrive continuing. 7/28/08-records received for DOS 12/4/07-10 day history of diarrhea, watery stools, spitting up, fever up to 104, rash on legs, URI for past 1 1/2 weeks. 1/2/08-consultant-FMH: immune deficiency. Onset of diarrhea coincided with starting day care and has been continuously ill with upper respiratory infection. Fallen off the growth curve due to weight loss consistent with malnutrition. 2/4/08-seen for eye drainage, no gastrointestinal symptoms.